Human papillomavirus in vaginal intraepithelial neoplasia

International Journal of Cancer

Volumn 131, Issue 3, 2012, Pages

  Chao, Angel ^a   Chen, Tse Ching ^a   Hsueh, Chuen ^a   Huang, Chu Chun ^a   Yang, Jung Erh ^a   Hsueh, Swei ^a   Huang, Huei Jean ^a   Lin, Cheng Tao ^a   Tang, Yun Hsin ^a   Liou, Jui Der ^a   Chang, Chee Jen ^b   Chou, Hung Hsueh ^a   Lai, Chyong Huey ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

genotype; HPV; vaginal intraepithelial neoplasia

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VAGINAL INTRAEPITHELIAL NEOPLASIA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; BASE SEQUENCE; CARCINOMA IN SITU; DNA, VIRAL; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; YOUNG ADULT;

EID: 84861576471     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27354     Document Type: Article

References (26)

1. Duong TH, Flowers LC,. Vulvo-vaginal cancers: risks, evaluation, prevention and early detection. Obstet Gynecol Clin North Am 2007; 34: 783-802.
2. Aho M, Vesterinen E, Meyer B, Purola E, Paavonen J,. Natural history of vaginal intraepithelial neoplasia. Cancer 1991; 68: 195-7.
3. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H,. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002; 84: 263-70.
4. Sherman JF, Mount SL, Evans MF, Skelly J, Simmons-Arnold L, Eltabbakh GH,. Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus. Gynecol Oncol 2008; 110: 396-401.
5. Barzon L, Pizzighella S, Corti L, Mengoli C, Palu G,. Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus. J Med Virol 2002; 67: 401-5.
6. Liao JB, Jean S, Wilkinson-Ryan I, Ford AE, Tanyi JL, Hagemann AR, Lin LL, McGrath CM, Rubin SC,. Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity. Gynecol Oncol 2011; 120: 108-12.
7. Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A,. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol 2006; 107: 1023-8.
8. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM,. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 2009; 113: 917-24.
9. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S,. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124: 1626-36.
10. Insinga RP, Liaw KL, Johnson LG, Madeleine MM,. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008; 17: 1611-22.
11. Sugase M, Matsukura T,. Distinct manifestations of human papillomaviruses in the vagina. Int J Cancer 1997; 72: 412-5.
12. Logani S, Lu D, Quint WG, Ellenson LH, Pirog EC,. Low-grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining. Mod Pathol 2003; 16: 735-41.
13. Vinokurova S, Wentzensen N, Einenkel J, Klaes R, Ziegert C, Melsheimer P, Sartor H, Horn LC, Hockel M, von Knebel Doeberitz M,. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst 2005; 97: 1816-21.
14. Srodon M, Stoler MH, Baber GB, Kurman RJ,. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 2006; 30: 1513-8.
15. Ferreira M, Crespo M, Martins L, Felix A,. HPV DNA detection and genotyping in 21 cases of primary invasive squamous cell carcinoma of the vagina. Mod Pathol 2008; 21: 968-72.
16. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374: 301-14.
17. Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia P, Ault KA, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. Br Med J 2010; 341: c3493.
18. Balamurugan A, Ahmed F, Saraiya M, Kosary C, Schwenn M, Cokkinides V, Flowers L, Pollack LA,. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer 2008; 113: 2919-25.
19. Chao A, Jao MS, Huang CC, Huang HJ, Cheng HH, Yang JE, Hsueh S, Chen TC, Qiu JT, Lin CT, Fu CJ, Chou HH, et al. Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women. Int J Cancer 2011; 128: 653-9.
20. Lai CH, Huang HJ, Hsueh S, Chao A, Lin CT, Huang SL, Chao FY, Qiu JT, Hong JH, Chou HH, Chang TC, Chang CJ,. Human papillomavirus genotype in cervical cancer: a population-based study. Int J Cancer 2007; 120: 1999-2006.
21. Chouhy D, Gorosito M, Sanchez A, Serra EC, Bergero A, Fernandez Bussy R, Giri AA,. New generic primer system targeting mucosal/genital and cutaneous human papillomaviruses leads to the characterization of HPV 115, a novel Beta-papillomavirus species 3. Virology 2010; 397: 205-16.
22. Chao FY, Chao A, Huang CC, Hsueh S, Yang JE, Huang HJ, Wang LC, Lin CT, Chou HH, Lai CH,. Defining detection threshold and improving analytical proficiency of HPV testing in clinical specimens. Gynecol Oncol 2010; 117: 302-7.
23. Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD,. A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis 2007, 34: 849-55.
24. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
25. Parkin DM, Louie KS, Clifford G,. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine 2008; 26 (Suppl 12): M1-16.
26. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Koutsky LA,. Comparison of incident cervical and vulvar/vaginal human papillomavirus infections in newly sexually active young women. J Infect Dis 2009; 199: 815-8.